Clinical trial

Stanford Regulating Circuits of the Brain Study - MDMA

Stanford UniversityCompletedStarted Nov 2, 202122 enrolledUnited StatesNCT04060108

Abstract

This study is a biomarker study designed to characterize how human neural circuits and behaviors are modified during altered states induced by MDMA.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

MDMA

Keywords

Healthy

View on registry

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

This study's objects

Directly linked records, matched by DOI, trial reference, or registry, not just topic.

Publications from this trial

ArticleMDMA

Negative Affect Circuit Subtypes and Neural, Behavioral, and Affective Responses to MDMA: A Randomized Clinical Trial.

Zhang X, Hack LM, Bertrand C +11

Europe PMC2025

Related research

ArticleMDMA

Chemsex drugs: More than ghb, mephedrone and methamphetamine?

Ramos J, Dolengevich H, Romerosa M +1

Europe PMC2021

ArticleMDMA

The effect of methamphetamine and 3,4-methylenedioxymethamphetamine on peripheral endocannabinoid concentrations: a study in healthy adults.

Deutsch A, Haggarty CJ, Petrie GN +4

Europe PMC2026

ArticleMDMA

Aesthetic mediation and lateral agency: Rethinking trauma and drug consumption in 'crisis ordinariness'.

Fomiatti R, Keane H, Nourse G +4

Europe PMC2026